Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Showing 49–66 of 66 articles · Keyword: transfection Clear keyword

Gene Therapy2010ReviewNon-viral Gene Delivery

49. Progress and prospects: nuclear import of nonviral vectors

Lam Ap, Dean Da.

The nuclear envelope remains a major barrier to successful nonviral transfection and gene therapy. After exogenous DNA is delivered to the cytoplasm, it rapidly complexes with cellular proteins that control its intracellular trafficking and nuclear import. Understanding these mechanisms is necessary to improve…

Read the article
Soft Matter2010ReviewNon-viral Gene Delivery

50. Polycation cytotoxicity a delicate matter for nucleic acid therapy—focus on polyethylenimine

Parhamifar, L.; Larsen, A. K.; Hunter, A. C.; Andresen, T. L.; Moghimi, S. M

Efficient transfection with low toxicity is essential for nucleic acid therapeutics, but synthetic polycations such as polyethylenimine (PEI) are limited by cytotoxicity. This review critically assesses the safety and efficacy challenges of PEI-based polyplexes, identifies deficiencies in the field, and proposes…

Read the article
European Journal of Pharmaceutical Sciences2010ReviewNon-viral Gene Delivery

51. Gene delivery by lipoplexes and polyplexes

Conchita Tros De Ilarduya, Yan Sun, Nejat Düzgüneş

Viral vectors achieve high gene transfer efficiency but can induce immune/inflammatory responses, have limited DNA carrying capacity, and raise recombination and cost concerns. Non-viral vectors such as cationic lipids and polymers are safer alternatives, but their transfection efficiency—especially in vivo—remains…

Read the article
Expert Opinion on Drug Delivery2010ReviewNon-viral Gene Delivery

52. Lipid and polymeric carrier-mediated nucleic acid delivery

Zhu L, Mahato Ri

Nucleic acid therapeutics—plasmid DNA, antisense oligonucleotides, and RNAi molecules—have broad therapeutic potential but face major biological barriers, including nuclease degradation, poor membrane penetration, endosomal entrapment, nonspecific biodistribution, and immune activation. The review addresses how…

Read the article
2009ReviewNon-viral Gene Delivery

53. Degradable Polymers for Gene Delivery

Sunshine, J.; Bhise, N.; Green, J. J

Non-viral gene delivery needs safe and effective carriers. PEI is effective but cytotoxic, while viral vectors raise safety concerns. Degradable poly(β-amino ester)s may provide effective gene delivery with reduced cytotoxicity. This study investigates how small changes in polymer synthesis ratio and end-group…

Read the article
British Journal of Pharmacology2009ReviewNon-viral Gene Delivery

54. Chemical vectors for gene delivery a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers

Midoux P, Pichon C, Yaouanc J-J, Jaffrès P-A

Non-viral nucleic acid delivery systems—lipoplexes, polyplexes, and lipopolyplexes—are limited mainly by poor endosomal escape. The review examines whether histidine- and imidazole-containing carriers can exploit the acidic endosomal environment to destabilize membranes and improve cytosolic delivery of DNA, mRNA…

Read the article
Accounts of Chemical Research2008ReviewNon-viral Gene Delivery

55. A Combinatorial Polymer Library Approach Yields Insight into Nonviral Gene Delivery

Green, J. J.; Langer, R.; Anderson, D. G

Gene therapy has enormous therapeutic potential, but delivery remains the central bottleneck. Viral vectors are efficient but carry serious safety, immunogenicity, manufacturing, and cargo-capacity limitations. Nonviral vectors are safer and more scalable but typically orders of magnitude less effective. This Account…

Read the article
Expert Opinion on Therapeutic Patents2006ReviewNon-viral Gene Delivery

56. Gene delivery using cationic liposomes

Mcneil Se, Perrie Y

Cationic liposomes have been developed for gene delivery for almost 20 years, but despite extensive effort, there has been limited progress toward an effective pharmaceutical product. Their transfection efficiency remains insufficient, and most clinical trials still rely on more potent viral vectors despite viral…

Read the article
Nature Materials2006ReviewNon-viral Gene Delivery

57. Polymers for gene delivery across length scales

Putnam D

Synthetic polymer-based gene delivery vectors have been studied for two decades but remain far less efficient than viral vectors. The review addresses the need for improved design criteria and new synthetic strategies across nano-, micro-, and macroscale delivery systems to overcome formulation, organism-level, and…

Read the article
Journal of Controlled Release2006ReviewNon-viral Gene Delivery

58. Toxicity of cationic lipids and cationic polymers in gene delivery

Lv H, Zhang S, Wang B, Cui S, Yan J

Cationic lipids and polymers are promising non-viral gene delivery vectors because they are non-immunogenic, easy to produce, and not oncogenic, but toxicity remains a major obstacle to their clinical application. The review evaluates structural features of cationic compounds and summarises toxicity–structure…

Read the article
Gene Therapy2005ReviewNon-viral Gene Delivery

59. Nuclear entry of nonviral vectors

Dean Da, Strong Dd, Zimmer We.

Nonviral gene delivery is limited by multiple extracellular and intracellular barriers, but the nuclear envelope remains a major unresolved barrier, especially in nondividing cells. Plasmids must enter the nucleus to be transcribed, yet the mechanisms of plasmid nuclear import are much less understood than protein…

Read the article
Expert Opinion on Drug Delivery2005ReviewNon-viral Gene Delivery

60. Cationic liposomes for gene delivery

Sérgio Simões, Ana Da Silva Filipe, Henrique Faneca, Miguel Mano, Nuno Penacho, Nejat Düzgüneş, Maria C. Pedroso De Lima

Cationic liposome–DNA complexes (lipoplexes) are a potentially viable non-viral alternative to viral vectors for therapeutic gene delivery, but they suffer from limited delivery/gene expression efficiency, toxicity at higher concentrations, adverse interactions with serum and cell surfaces, and poor tissue access…

Read the article
Nature Reviews Drug Discovery2005ReviewNon-viral Gene Delivery

61. DESIGN AND DEVELOPMENT OF POLYMERS FOR GENE DELIVERY

Pack, D. W.; Hoffman, A. S.; Pun, S.; Stayton, P. S

The lack of safe and efficient gene-delivery methods remains a limiting obstacle to human gene therapy. Synthetic vectors are safer than recombinant viruses but generally lack sufficient efficacy, so polymers must be rationally designed to overcome extracellular and intracellular delivery barriers. PEI: Only 15–20%…

Read the article
2001ReviewNon-viral Gene Delivery

62. Design and gene delivery activity of modified polyethylenimines

Kircheis, R.; Wightman, L.; Wagner, E

PEI is one of the most effective non-viral gene delivery polymers, but its efficacy, toxicity, and in vivo behaviour depend strongly on molecular weight, branching, particle size, surface charge, and modifications. This review addresses how PEI/DNA complexes can be modified with targeting ligands, shielding agents…

Read the article
1999ReviewNon-viral Gene Delivery

63. Poly(ethylenimine) and its role in gene delivery

Godbey, W. T.; Wu, K. K.; Mikos, A. G

Gene therapy still lacks safe and efficient delivery vectors. PEI has emerged as a promising non-viral polycation because it condenses DNA and mediates endosomal escape, but its transfection mechanism, targeting potential, and toxicity require clearer understanding. This review summarises PEI chemistry, PEI/DNA…

Read the article
Molecular Membrane Biology1998ReviewNon-viral Gene Delivery

64. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (Review)

Hope Mj, Mui B, Ansell S, Ahkong Qf

Polymeric nucleic acid drugs—plasmid DNA, antisense oligonucleotides, and ribozymes—require protection from nucleases and efficient intracellular delivery to cytoplasm/nucleus. Viral vectors are efficient but immunogenic and safety-limited; non-viral cationic lipid systems are promising, but the mechanism of…

Read the article
1989ReviewNon-viral Gene Delivery

65. Cationic liposome-mediated transfection

Felgner Pl, Ringold Gm

Existing polynucleotide delivery methods—calcium phosphate, DEAE-dextran, electroporation, retroviral vectors—had limitations in convenience, reproducibility, efficiency, and applicability across cell types. A simple, broadly effective cationic liposome reagent was needed for DNA and RNA transfection of mammalian…

Read the article
ReviewNon-viral Gene Delivery

66. Delivery of therapeutic nucleic acids via transferrin and transferrin receptors lipoplexes and other carriers

The transferrin receptor (TfR) is overexpressed on many cancer cells and is efficiently internalised, making it a useful target for delivering small-molecule drugs and nucleic acid therapeutics while reducing non-target effects. The review summarises TfR biology, Tf-lipoplex development, and therapeutic applications…

Read the article
Articles — page 3 | Brilliant Blue Biosciences